MRI monitoring of myocardial iron overload: Use of cardiac MRI combined with hepatic MRI in a cohort of multi-transfused patients with thalassaemia

Diagnostic and Interventional Imaging

Volumn 95, Issue 11, 2014, Pages 1065-1069

  Quatre, A ^a   Jacquier, A ^b   Petit, P ^b   Giorgi, R ^b,c   Thuret, I ^b  

^a North University Hospital   (France)

^b TIMONE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Cardiac MRI; Hepatic MRI; Iron overload; T2 ; Thalassaemia

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; IRON CHELATING AGENTS;

ADULT; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IRON CHELATION; IRON OVERLOAD; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; THALASSEMIA; YOUNG ADULT; ADOLESCENT; ADVERSE EFFECTS; CARDIOMYOPATHIES; FRANCE; HUMANS; MAGNETIC RESONANCE IMAGING; METHODS; MYOCARDIUM; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; STROKE VOLUME;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CARDIOMYOPATHIES; FEMALE; FRANCE; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; STROKE VOLUME; THALASSEMIA; YOUNG ADULT;

EID: 84924527170     PISSN: None     EISSN: 22115684     Source Type: Journal    
DOI: 10.1016/j.diii.2014.01.007     Document Type: Article

References (20)

1. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A,Melevendi C, et al. Survival and causes of death in thalassaemiamajor. Lancet 1989;2:27-30.
2. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Llu PP,McGee A, et al. Survival in medically treated patients withhomozygous betathalassaemia. N Engl J Med 1994;331:574-8.
3. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H,Cappellini MD, Del Vecchio GC, et al. Survival andcomplications in patients with thalassemia major treatedwith transfusion and deferoxamine. Haematologica2004;89:1187-93.
4. Kirk P, He T, Anderson LJ, Roughton M, Tanner MA, Lam WW,et al. International reproductibility of single breathhold T2∗MRfor cardiac and liver iron assessment among five thalassemiacenters. J Magn Reson Imaging 2010;32:315-9.
5. Anderson LJ, Holden S, Davies B, Prescott E, Charrier C,Bunce NH, et al. Cardiovascular T-star (T2∗) magnetic reso-nance for the early diagnosis of myocardial iron overload. EurHeart J 2001;22:2171-9.
6. Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J,et al. Cardiac T2∗magnetic resonance for predictionof cardiac complications in thalassemia major. Circulation2009;120:1961-8.
7. http://oernst.f5lvg.free.fr/liver/fer/fer.html#coeur
8. Ernst O, Thuret I, Petit P, Ameur F, Loundou AD, De kervilier E,et al. Iron overload of hematological origin: Validationof a screening procedure for cardiac overload by MRI inroutine clinical practice. Diagn Interv Imaging 2013;94:601-8.
9. Ernst O, Rose C, Sergent G, L'Hermine C. Hepatic iron overload:quantification with MR imaging at 1. 5 T. AJR 1999;172:1141-2.
10. R Core Team. R: A language and environment for statisticalcomputing. Vienna, Austria: R Foundation for Statistical Com-puting; 2012 http://www.R-project.org/
11. Westwood MA, Anderson LJ, Maceira AM, Shah FT, Prescott E,Porter JB, et al. Normalized left ventricular volumes and func-tion in thalassemia major patients with normal myocardial iron.J Magn Reson Imaging 2007;25:1147-51.
12. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC,Bunce NH, et al. Cardiovascular T-star (T2∗) magnetic reso-nance for the early diagnosis of myocardial iron overload. EurHeart J 2001;22:2171-9.
13. Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD. Myocar-dial iron loading in transfusion-dependent thalassemia andsickle cell disease. Blood 2004;103:1934-6.
14. Mavrogeni S, Gotsis ED, Berdousi E, Ladis V, Verganelakis D,Toulas P, et al. Myocardial and hepatic T2∗magnetic resonanceevaluation in ex-thalassemic patients after bone-marrow trans-plantation. Int J Cardiovasc Imaging 2007:1569-5794.
15. Chacko J, Pennell DJ, Tanner MA, Hamblin TJ, Wonke B, Levy T,et al. Myocardial iron loading by magnetic resonance imag-ing T2∗in good prognostic myelodysplastic syndrome patientson long-term blood transfusions. Br J Haematol 2007;138:587-93.
16. Mavrogeni SI, Markussis V, Kaklamanis L, Tsiapras D, Paraske-vaidis I, Karavollas G, et al. A comparison of magneticresonance imaging and cardiac biopsy in the evaluation of heartiron overload in patients with beta-thalassemia major. Eur JHaematol 2005;75:241-7.
17. Konen E, Ghoti H, Goitein O, Winder A, Kushnir T, Eshet Y, et al.No evidence for myocardial iron overload in multi-transfusedpatients with myelodysplastic syndrome using cardiac mag-netic resonance T2∗technique. Am J Hematol 2007;11:1013-6.
18. Ernst O, Sergent G, Bonvarlet P, Canva-Delcambre V, Paris JC,L'Hermine C. Hepatic iron overload: Diagnosis and quantifica-tion with MR imaging. AJR 1997;168:1205-8.
19. Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E,Wonke B, et al. Myocardial iron clearance during reversal ofsiderotic cardiomyopathy with intravenous desferrioxamine:a prospective study using T2∗cardiovascular magnetic reso-nance. Br J Haematol 2004;127:348-55.
20. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA,Agus A, et al. A randomized, placebo-controlled, double-blindtrial of the effect of combined therapy with deferox-amine and deferiprone on myocardial iron in thalassemiamajor using cardiovascular magnetic resonance. Circulation2007;115:1876-84.